The Advisory Committee on Immunization Practices (ACIP) is a group of medical and public health experts that develop recommendations on use of vaccines in the civilian population of the United States.
The Beers List was initially compiled in 1993 by Dr. Beers to help clinicians determine which medications should be avoided in nursing home patients since seniors in nursing homes are particularly at risk for suffering medication-related problems.
BRAND EFFECTIVE RATE
Title: Section 80.112 - Inventory; procedure for filing
80.112 Inventory; procedure for filing. (a) All manufacturers, distributors, importers, and exporters licensed to deal in controlled substances; all institutional dispensers and persons conducting research, instructional activities, maintenance treatment programs and analytical laboratories certified for controlled substance privileges; and all physicians, dentists, podiatrists, veterinarians and other practitioners, and all pharmacies possessing, having under their control, selling, prescribing, administering, dispensing or compounding any controlled substances in New York State shall as of May 1, 1975 and every two years thereafter, prepare and maintain an inventory of all controlled substances specified by the State Commissioner of Health by regulation as substances requiring inventory. A separate entry shall be made with respect to each kind of substance or preparation, and each kind or size of package. Each entry shall show the name, quantity and content of controlled substance and the size of the individual package, the number of packages and the total content of all packages covered by the entry on hand as of the date of the inventory. Maintaining for inspection a biennial inventory of controlled substances prepared and maintained in compliance with federal statute and regulations shall be deemed compliance with this section.
(b) A copy of the inventory shall be retained on file with other controlled substances records, and shall be kept available for inspection for at least five years.
This type of warning is also commonly referred to as a “black box warning.” It is designed to call attention to serious or life-threatening risks. Boxed warnings are displayed on a drug's package insert, in the Physicians' Desk Reference, on the FDA's Web site, and on the Web sites of drug marketing companies.
The healthy DASH diet plan was developed to lower blood pressure without medication in research sponsored by the US National Institutes of Health, Dietary Approaches to Stop Hypertension.
The DEA form 222 is used to order C-II controlled substances. It is a three part form. Copy 1 is retained by the supplier, Copy 2 is sent to the local DEA office, and the purchaser records on Copy 3 the receiving of the order and keeps the form on hand.
To check a DEA number: AB1234563 Add the sum of digits 1,3,5 (1+3+5=9) To twice the sum of digits 2,4,6 2(2+4+6)=24 THE DIGIT IN THE ONES PLACE FOR THE ANSWER SHOULD EQUAL DIGIT 7 (24+9=33)
The Drug Efficacy Study Implementation (DESI) was a program begun by the Food and Drug Administration in the 1960s requiring all drugs to be efficacious as well as safe. Drugs which had been previously approved as “safe” prior to 1962 were required to be studied for effectiveness. If DESI does not find substantive evidence that a drug is effective for each labeled indication, it is considered “less-than-effective” and recommended for removal from the market by the FDA.
Dispense Fee Effective Rate
A DFER is a PSAO-level effective rate guarantee that specifies the overall average dispense fee at which PBMs will reimburse a PSAO pharmacy network per claim over the course of the contract year. At the pharmacy level, pharmacies can experience variable dispensing fees.
The Medication Safety Program, housed in the Division of Healthcare Quality Promotion (DHQP), leads CDC’s national adverse drug events (ADEs) surveillance activities and seeks to translate population-based surveillance data into evidence-based policies and targeted, innovative and collaborative interventions. The mission of the Division of Healthcare Quality Promotion (DHQP) is to protect patients; protect healthcare personnel; and promote safety, quality, and value in both national and international healthcare delivery systems.
NABP became the registry operator for the .pharmacy domain to create a safe online environment where consumers can be confident that the websites where they buy medication or obtain information are safe and legitimate.
CPE (continuing pharmacy education) Monitor, through the collaborative efforts of NABP (National Association of Boards of Pharmacy), the Accreditation Council for Pharmacy Education (ACPE), and ACPE providers, allows you to electronically keep track of CPE credits from ACPE-accredited providers. To view and track these credits, you must first set up an NABP e-Profile, obtain your NABP e-Profile ID, and register for CPE Monitor.
The Employee Retirement Income Security Act of 1974 (ERISA) is a federal law that sets minimum standards for most voluntarily established pension and health plans in private industry to provide protection for individuals in these plans.
ICD-10 is the tenth revision of the International Statistical Classification of Diseases and Related Health. It is a list of medical diagnosis and classifications by the World Health Organization. It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases
I-STOP/PMP - Internet System for Tracking Over-Prescribing - Prescription Monitoring Program: Effective August 27, 2013, most prescribers are required to consult the Prescription Monitoring Program (PMP) Registry when writing prescriptions for Schedule II, III, and IV controlled substances. The PMP Registry provides practitioners with direct, secure access to view dispensed controlled substance prescription histories for their patients. The PMP is available 24 hours a day/7 days a week via an application on the Health Commerce System (HCS) Here. Patient reports will include all controlled substances that were dispensed in New York State and reported by the pharmacy/dispenser for the past six months. This information will allow practitioners to better evaluate their patients' treatment with controlled substances and determine whether there may be abuse or non-medical use. https://www.health.ny.gov/professionals/narcotic/prescription_monitoring/
Education Law, Article 137, Pharmacy §6810. Prescriptions. Nothing in this subdivision shall prevent a pharmacy from furnishing a drug to another pharmacy which does not have such drug in stock for the purpose of filling a prescription. K.O.W. = Kindly Oblige With
Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. FDA requires that Medication Guides be issued with certain prescribed drugs and biological products when the Agency determines that: ● certain information is necessary to prevent serious adverse effects ● patient decision-making should be informed by information about a known serious side effect with a product, or ● patient adherence to directions for the use of a product are essential to its effectiveness. FDA Medication Guides are available on their website at http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm * There is one medication guide that can be used for all NSAIDs.
Pursuant to Title 21, Code of Federal Regulations, Section 1300.01(b28), the term mid-level practitioner means an individual practitioner, other than a physician, dentist, veterinarian, or podiatrist, who is licensed, registered, or otherwise permitted by the United States or the jurisdiction in which he/she practices, to dispense a controlled substance in the course of professional practice. In New York the most common mid-level practitioners are nurse practitioners and physician assistants.
The Multistate Pharmacy Jurisprudence Examination (MPJE) is a pharmacy law examination created by the National Association of Boards of Pharmacy (NABP) to help individual state boards of pharmacy assess the competency and knowledge of pharmacy law.
NABP stands for the National Association of Boards of Pharmacy. The NCPDP Provider Identification number (NCPDP Provider ID) formerly known as the NABP number, was developed over 25 years ago to provide pharmacies with a unique, national identifier that would assist pharmacies in their interactions with pharmacy payers and claims processors. The NCPDP Provider ID is a seven-digit numbering system that is assigned to every licensed pharmacy and qualified Non-Pharmacy Dispensing Sites (NPDS) in the United States.
Federal law (under the National Childhood Vaccine Injury Act) requires a healthcare provider to give a copy of the current VIS to an adult patient or to a child’s parent/legal representative before vaccinating an adult or child with a dose of the following vaccines: diphtheria, tetanus, pertussis, measles, mumps, rubella, polio, hepatitis A, hepatitis B, Haemophilus influenzae type b (Hib), influenza, pneumococcal conjugate, meningococcal, rotavirus, human papillomavirus (HPV), or varicella (chickenpox).
Although many pharmacists do require a written waiver, the law and regulations do not require a written request. The Consumer Product Safety Commission recommends that the pharmacist get a request in writing particularly when a blanket waiver is being requested. This will assist the pharmacist during inspections of the pharmacy by regulatory agencies as well in legal issues.
New York State Immunization Information System
The New York State Department of Health's (NYSDOH) Bureau of Immunization is committed to promoting the health of New York State children by reducing and/or eliminating the number of vaccine preventable diseases that affect the State's children.
As part of this effort, the New York State legislature passed the Immunization Registry Law which, as of January 1, 2008, requires health care providers to report all immunizations administered to persons less than 19 years of age, along with the person's immunization histories, to the New York State Department of Health using the New York State Immunization Information System (NYSIIS).
The goal of the new immunization information system is to establish a complete, accurate, secure, real-time immunization medical record that is easily accessible and promotes public health by fully immunizing all individuals appropriate to age and risk.
One-house budgets are frequently viewed as a statement of competing priorities. The Senate passes its version, and the Assembly passes its own. A negotiation then takes place between the two sides along with Governor
The publication Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the Orange Book) identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act) and related patent and exclusivity information
PPIs fall into several categories. Some drugs, by regulation, are required to have PPIs that must be distributed to patients (i.e., oral contraceptives, estrogens). The PPIs for oral contraceptives and estrogen products are intended to fully inform the patient of the benefits and risks associated with the use of these drugs. Other drugs are approved on the condition that the drug is packaged so that patients receive a PPI when receiving their prescription (e.g., unit-of-use packaging). Some drugs have PPIs, but the PPIs are not required to be dispensed to a patient (e.g., Fosamax [alendronate]). However, if a PPI is included in the manufacturer's container or box from which the drug is dispensed, the pharmacist can give the PPI to the patient. FDA prescription labeling rules require that PPIs be included in the medication container. And of course some drugs don't have a PPI.
A pharmacy benefit manager (PBM) is a third-party administrator of prescription drug programs. PBMs are primarily responsible for developing and maintaining the formulary, contracting with pharmacies, negotiating discounts and rebates with drug manufacturers, and processing and paying prescription drug claims.
Person-based Electronic Response Data System
PERDS is used to track adverse events related to medical marijuana products or devices and to help the Medical Marijuana Program identify potential public health risks through the information reported.
The 13th Edition Epidemiology and Prevention of Vaccine-Preventable Diseases, a.k.a. the "Pink Book," provides physicians, nurses, nurse practitioners, physician assistants, pharmacists, and others with the most comprehensive information on routinely used vaccines and the diseases they prevent.
Poison", where not otherwise limited, means any drug, chemical or preparation likely to be destructive to adult human life in quantity of sixty grains or less. Education Law, Article 137, §6802. Definition
Shall be designated Preceptor Pharmacist • Shall have practiced for at least one year immediately preceding rotation • Shall supervise not more than one full-time intern nor more than two part-time interns at a time • One intern may be supervised for each 5,000* prescriptions and/or drug orders dispensed annually by the pharmacy and for a major fraction thereof over a multiple of 5,000 Regulations of the Commissioner, Part 63, §63.2. Experience * This calculates out to 96.15 per week.
The Professional Assistance Program (PAP) assists professionals who have substance abuse problems, but who have not harmed patients or clients. Such professionals may voluntarily surrender their licenses while receiving treatment rather than face charges of professional misconduct. All applications to the program are confidential. • PAP Brochure • PAP Application Packet
Class 1 - There is a strong likelihood that the product will cause serious adverse effects or death. Class 2 - A product may cause reversible adverse effects and there is little likelihood of serious adverse effects. Class 3 - The product is not likely to cause adverse effects.
The RED BOOK™ Database presents pricing and descriptive information for over 200,000 healthcare items, including prescription and nonprescription pharmaceuticals, chemicals used for compounding and medical devices and supplies.
The registered area of a pharmacy shall include a refrigerator, sufficient in capacity to serve the needs of the pharmacy, that is equipped with a thermometer and providing at all times a storage temperature of 2 degrees to 8 degrees Centigrade (36 degrees to 46 degrees Fahrenheit). The use of such refrigerator shall be limited to the storage of drugs. Source: Regulations of the Commissioner, Part 63.6, b, 8 ***No personal food or drink items allowed in the refrigerator***
An alternative for controlled substance disposal is to surrender the substances to an approved independent company. Companies must be licensed by the Department of Health to receive such substances and registered with the Drug Enforcement Administration.
Regional Health Information Organizations (RHIOs)
A RHIO, or QE (Qualified Entity), is a local hub where a region’s electronic health information is stored and shared. There are eight RHIOs in New York State that each cover different areas from Buffalo to New York City. These RHIOs are the backbone of the SHIN-NY, providing the services that make secure, vital access to a patient’s health information possible statewide.
HIPAA allows for the provider of care to use health information for Treatment, Payment and Operations (TPO). Patients need to give prior authorization for the use of the health information for non- TPO purposes.
The United States Adopted Names Council designates non-propriety names (generic) for drugs. FDA’s Division of Medication Error Prevention and Analysis is responsible for proprietary name review prior to approval.
The science is clear. People living with HIV can feel confident that if they have an undetectable viral load and take their medications properly, they will not pass on HIV to sexual partners (Undetectable = Untransmittable U=U).
To secure and retain registration, a pharmacy shall be equipped with at least the following utensils: 1.weighing device sensitive to 6 mg; 2.metric weights, if needed for the operation of the device in subparagraph (i) of this paragraph; 3.devices capable of measuring volumes from 0.1 ml to 500 ml; and 4. a mortar and pestle. Source: Regulations of the Commissioner, Part 63.6, b, 1Required Weighing and Measuring Devices